Join us on HemeTalks as Dr. Christin DeStefano and Dr. Drew Helmer discuss the impact of military toxic exposures on the development of hematologic malignancies, including leukemia, lymphoma, and myeloma. Learn about the challenges of diagnosing and treating these cancers, advancements in research, and strategies for improving care for military members and veterans. Learning Objectives:Discuss challenges in studying the effects of toxic exposures commonly experienced during military service and their links to hematologic cancers. Understand the unique evaluation and treatment challenges for hematologic malignancies in veterans and active-duty military members. Explore hematology-specific research and initiatives aimed at improving early detection and care for this population.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related